(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.05%.
Anixa Biosciences's earnings in 2026 is -$10,034,000.On average, 6 Wall Street analysts forecast ANIX's earnings for 2026 to be -$12,061,176, with the lowest ANIX earnings forecast at -$12,670,189, and the highest ANIX earnings forecast at -$11,074,507. On average, 5 Wall Street analysts forecast ANIX's earnings for 2027 to be -$12,493,269, with the lowest ANIX earnings forecast at -$12,670,189, and the highest ANIX earnings forecast at -$11,788,991.
In 2028, ANIX is forecast to generate -$11,799,198 in earnings, with the lowest earnings forecast at -$11,336,485 and the highest earnings forecast at -$12,146,233.